These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32315465)

  • 21. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
    Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
    Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of EpCAM
    Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
    Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization.
    Sterlacci W; Savic S; Fiegl M; Obermann E; Tzankov A
    J Thorac Oncol; 2014 Jan; 9(1):41-9. PubMed ID: 24346092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
    Mărgăritescu C; Pirici D; Simionescu C; Stepan A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.
    Hoe SLL; Tan LP; Abdul Aziz N; Liew K; Teow SY; Abdul Razak FR; Chin YM; Mohamed Shahrehan NA; Chu TL; Mohd Kornain NK; Peh SC; Koay CE; Lo KW; Ahmad M; Ng CC; Khoo AS
    Sci Rep; 2017 Sep; 7(1):12372. PubMed ID: 28959019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
    Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
    Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma.
    Zheng S; Liu Q; Liu T; Yang L; Zhang Q; Shen T; Zhang X; Han X; Lu X
    Biochem Biophys Res Commun; 2020 May; 526(1):29-34. PubMed ID: 32192776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44+/CD24+-Expressing Cervical Cancer Cells and Radioresistant Cervical Cancer Cells Exhibit Cancer Stem Cell Characteristics.
    Zhang J; Chen X; Bian L; Wang Y; Liu H
    Gynecol Obstet Invest; 2019; 84(2):174-182. PubMed ID: 30317240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells.
    Wu Y; Zhang Y; Niu M; Shi Y; Liu H; Yang D; Li F; Lu Y; Bo Y; Zhang R; Li Z; Luo H; Cui J; Sang J; Xiang C; Gao W; Wen S
    Cell Physiol Biochem; 2018; 47(4):1696-1710. PubMed ID: 29949786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.
    Gao W; Wu D; Wang Y; Wang Z; Zou C; Dai Y; Ng CF; Teoh JY; Chan FL
    Stem Cell Res Ther; 2018 Sep; 9(1):243. PubMed ID: 30257704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of flavopiridol on critical regulation pathways of CD133high/CD44high lung cancer stem cells.
    Bozok Cetintas V; Acikgoz E; Yigitturk G; Demir K; Oktem G; Tezcanli Kaymaz B; Oltulu F; Aktug H
    Medicine (Baltimore); 2016 Oct; 95(43):e5150. PubMed ID: 27787370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma.
    Sun Y; Han J; Lu Y; Yang X; Fan M
    Oral Dis; 2012 Mar; 18(2):169-77. PubMed ID: 22023137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
    Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
    Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S; Black J; English DP; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Ferrari F; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Am J Obstet Gynecol; 2016 Jan; 214(1):99.e1-8. PubMed ID: 26272866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.